What can we do for you?

+49 7082 7916-0info[at]stratec.com

Stock
Information

Stock
Information

This site provides detailed information about STRATEC's stock performance, financial metrics, and market outlook, offering insights for potential investors and stakeholders.

03/26/2025 12:57 CET EUR 25.45
Change from
previous day
-1.74%
-0.45 EUR
WKN STRA55ISIN DE000STRA555Xetra

Today

Previous dayEUR 25.90
OpenEUR 25.55
Intraday highEUR 25.55
Intraday lowEUR 25.20
Volume2,228.00
TurnoverEUR 56,551.75
Market capEUR 314.89 Mln

Overview

YTD highEUR 48.60
YTD lowEUR 25.50
1 day-1.74%
1 month-10.07%
3 months-15.45%
Year to date-14.45%
STOCK CHART
BASIC DATA
KEY FIGURES
SHAREHOLDER STRUCTURE
VOTING RIGHTS
ANALYSTS

 

Title
Data

ISIN

DE000STRA555

WKN

STRA55

Symbol

SBS

Reuters Intrument Code

SBSG.DE

Bloomberg Instrument Code

SBS:GR

Segment

Prime Standard

Market

Regulated Market

Type

Common Shares

Form

Registered Shares

Sector

Pharma & Healthcare

Subsector

Medical Technology

Registered capital

12,157,841 Euro

No. of shares

12,157,841

Initial listing

August 25, 1998

Designated exchanges

Xetra; Frankfurt am Main
and other regional exchanges in Germany

Designated Sponsor

Hauck & Aufhäuser Privatbankiers AG

Related indices

SDAX
CDAX
Prime All Share
DAXsubsector Medical Technology

Accounting standard

IFRS

End of financial year

December 31

 

 

 

 
 
2023
2022
2021
2020
2019

Annual low (Xetra)

EUR

36.00

72.70

100.40

46.40

49.30

Annual high (Xetra)

EUR

93.00

138.60

147.40

144.60

77.60

Closing price (Xetra)

EUR

45.55

81.10

137.80

122.80

61.00

Annual performance excluding dividend

%

-43.8

-41.1

+12.2

+101.3

+21.3

Average trading volume per trading day

EUR
Shares

555,652
9,916

1,240,704
12,260

1,489,029
12,041

2,217,521
22,615

326,410
5,124

Number of shares

Mio. shares

12.2

12.2

12.1

12.1

12.0

Market capitalization

Mio. EUR

553.8

986.0

1671.2

1486.2

733.8

Dividend per share

EUR

0.55

0.97

0.95

0.90

0.84

Total dividend distribution

Mio. EUR

6.7

11.8

11.5

10.9

10.1

Dividend yield

%

1.2

1.2

0.7

0.7

1.4

 

STRATEC has a broad share ownership structure. Free float shares account for 59.62% and are held by numerous international and national investors. 40.38% of the shares are in fixed ownership. Of these, 0.02% are treasury stock held by STRATEC itself.

40.36% of the shares are attributable to the company's founder, Hermann Leistner, and to his family and investment companies.

Shareholder structure of STRATEC

 

Under the German Securities Trading Act (Wertpapierhandelsgesetz, WpHG) shareholders and individuals having access to voting rights are obliged to notify the issuer and the Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht, BaFin) immediately when reaching, exceeding or falling below the thresholds of 3 %, 5 %, 10 %, 15 %, 20 %, 25 %, 30 %, 50 % or 75 % of the voting rights in a publicly listed company either through the acquisition or disposal of shares or other financial instruments or by any other means (§§ 33, 38 and 39 WpHG). The issuer is obliged to release any notification of voting rights without delay.

We kindly request that any shareholders obliged to inform STRATEC SE about changes in voting right shares send a relevant notification by e-mail to the Investor Relations department (e-mail address: ir[at]stratec.com).

STRATEC has received the following notifications of voting rights:

2025
2024
2023
2022
2021
no content available.

 

The following institutions analyze STRATEC SE on a regular basis:

INSTITUTEANALYSTSPHONE
Berenberg BankOdysseas Manesiotis+44 20 37533200
Deutsche BankJan Koch+49 69 91047428
DZ BankSven Kürten+49 69 744792072
Hauck Aufhäuser Investment BankingAlexander Galitsa+49 40 414388583
Kepler CheuvreuxOliver Reinberg+49 69 75696140
Metzler Capital MarketsAlexander Neuberger+49 69 21044366
mwb researchHarald Hof+49 40 30929358
ODDO BHFOliver Metzger+49 69 7183045
Warburg ResearchMichael Heider+49 40 309537280

For various practical reasons, we are unable to provide all research reports available on the market. To ensure equal treatment and avoid highlighting any individual report, we do not publish any research reports on this website. We apologize for any inconvenience this might cause. However, the relevant information is generally available on finance portals on the internet.

Please note that STRATEC SE has no influence whatsoever on the opinions, assessments, or forecasts issued by the aforementioned institutions or their employees with regard to STRATEC SE or its performance. These are merely provided for information purposes, do not represent the opinion, assessment, or forecast of STRATEC SE, and are solely the responsibility of the aforementioned institutions or their employees.

Reference to these institutions in no way constitutes any confirmation or approval of the contents of the analyses compiled by these institutions or their employees. This list should under no circumstances be viewed as representing a request or solicitation to buy, sell, or hold shares in STRATEC SE, or as representing any other recommendation relevant to investment decisions.